• US: +1 9176726599
  • Login

Gene Panel Market Status (2016-2020) and Forecast Market Analysis, Regional Outlook, Segment Growth Potential, and Competitive Market Share Analysis, 2021-2027

Format: PDF | Pages: 264 | Report ID: MRS1118


Report Description

The global Gene Panel market size is estimated at USD 2,000.5 million in 2020, expanding at a CAGR 23.4% from 2021-2027 to reach 6,900.8 Million USD in 2027.

Market Dynamics

The rising complexity of cancer occurrences in both men and women, as well as the advantages supplied by the genetic panel marketplace to combat cancer, drive industry expansion. Another aspect that contributes to market expansion is the rising effectiveness with which the industry operates. Additional element attributing to the industry's rapid expansion is technological improvement and an increased need for perinatal diagnostics.

The coronavirus outbreak has had an influence on the creation, manufacture, and distribution of medical items, as well as the operations of numerous medical corporations throughout the world. The outbreak has resulted in the shutdown of commercial enterprises, except for those producing vital goods, as well as disruptions in the distribution network of therapeutic goods. The increased occurrences of cardiac illnesses, osteoarthritis, among neurological disorders linked with the COVID-19 virus, on the other hand, are predicted to have a favorable influence on genetic panel industry development, since gene arrays may be utilized to diagnose such illnesses.

Regional Insights

The Gene Panel market is segmented into four regions: Europe, North America, Asia Pacific, and the Rest of the World. Throughout the projected timeline North America held the highest industry position and is expected to increase at the highest CAGR over the predicted timeframe. Customer demand for safe and effective genetic screening is propelling the gene panel business forward. Nevertheless, the increasing need for customized therapy and the increasing use of genetic analysis in cancer are propelling America's gene panel industry forward.

Segment Insights

The Gene Panel market is classified into four categories: Product and Service, Technique, Application, and end-user. Depending on Application, Cancer Risk Assessment had the greatest industry shares and is expected to increase at a rapid CAGR throughout the forecasted timeframe. Individuals identified as having heritable cancer may be subjected to additional testing and assistance in developing preventative and therapy initiatives. The American Culture of Breast Surgeons has announced revised recommendations that require genetic screening for all women with breast cancer in extra to normal imaging screenings to determine inherited risk.

Competitive Insights

The Gene Panel industry is extremely fragmented, with both domestic and foreign competitors present. To maintain competitiveness, key firms in the business participate in planned mergers and acquisitions, partnerships, and innovative product releases. For instance, The GENEWIZ (U.S.) is investing heavily in the gene panel industry r&d in order to maintain its worldwide industry leadership and extend its client base in order to increase sales income.

The report begins with an overview of the Industry Chain structure, and describes the industry environment, then analyses market size and forecast of Gene Panel by Product and Service, region, End-Use, Technique, and Application. In addition, this report introduces the market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):

  • Illumina
  • Agilent Technologies
  • ArcherDx
  • BGI
  • CENTOGENE AG
  • Eurofins Scientific
  • F. Hoffmann-La Roche AG
  • GATC Biotech AG
  • GeneDx Inc.
  • GENEWIZ, Inc.
  • Illumina
  • Integrated DNA Technologies
  • Invitae Corporation
  • Novogene Corporation
  • Personalis
  • QIAGEN
  • Thermo Fisher Scientific

Product and Service Coverage (Market Size & Forecast, Main Consumer Analysis, etc.):

  • Test Kits
  • Testing Services

Technique Coverage (Market Size & Forecast, Main Consumer Analysis, etc.):

  • Amplicon-based Approach
  • Hybridization-based Approach

Application Coverage (Market Size & Forecast, Main Consumer Analysis, etc.):

  • Diagnosis of Congenital Diseases
  • Cancer Risk Assessment
  • Pharmacogenetics
  • Others

End-Use Coverage (Market Size & Forecast, Main Consumer Analysis, etc.):

  • Hospitals
  • Diagnostic Laboratories
  • Pharmaceutical Companies
  • Others

Region Coverage (Regional Consumption, Demand & Forecast by Countries, etc.):

  • North America (U.S., and Canada)
  • Europe (Germany, U.K., France, Italy, Spain etc.)
  • Asia-Pacific (China, India, Japan, Indonesia, Malaysia, Australia, South Korea, etc.)
  • South America (Brazil, Mexico, Argentina etc.)
  • Middle East & Africa (Saudi Arabia, Kuwait, UAE, South Africa etc.)

Frequently Asked Questions

The global Gene Panel market size is estimated at USD 2,000.5 million in 2020, expanding at a CAGR 23.4% from 2021-2027 to reach 6,900.8 Million USD in 2027.
North America captured the highest revenue in 2021 and is projected to continue its dominance during the study period.
The global Gene Panel market size is expanding at a CAGR 23.4% from 2021-2027 to reach 6,900.8 Million USD in 2027.
Asia Pacific (especially China, and India) region is projected to grow at the fastest growth rate during the study period.
The Gene Panel industry is extremely fragmented, with both domestic and foreign competitors present. To maintain competitiveness, key firms in the business participate in planned mergers and acquisitions, partnerships, and innovative product releases. For instance, The GENEWIZ (U.S.) is investing heavily in the gene panel industry r&d in order to maintain its worldwide industry leadership and extend its client base in order to increase sales income.

Why Choose Market Research Strategy?

  Authenticated Data Sources

We utilize market analysis/information from verified authenticated data sources to scoop accurate research reports

  Express Delivery

We understand the urgency of our clients and their clients' in the competitive space thus, deliver the report in minimum turnaround

  Gain Instant Access

Without further ado, choose us and get instant access to reliable analysis to help you make the right business decisions.

  Our Pledge to You

We abide by the information security policy and adheres to keep your private and business information confidential and secure.

Copyright © 2022 Market Research Strategy, All rights reserved.